Pitx2 is a useful marker of midgut-derived neuroendocrine tumours - an immunohistochemical study of 224 cases
Language English Country England, Great Britain Media print-electronic
Document type Journal Article
Grant support
LM2018125
BBMRI-CZ
NV19-01-00435
Ministerstvo Zdravotnictví Ceské Republiky
Cooperatio Program DIAG
Univerzita Karlova v Praze
PubMed
36089904
DOI
10.1111/his.14789
Knihovny.cz E-resources
- Keywords
- NET, Otlx2, Pitx2, histogenesis, neuroendocrine tumours,
- MeSH
- Immunohistochemistry MeSH
- Humans MeSH
- Mice MeSH
- Biomarkers, Tumor analysis MeSH
- Skin Neoplasms * MeSH
- Carcinoma, Neuroendocrine * pathology MeSH
- Neuroendocrine Tumors * metabolism MeSH
- Paraganglioma * MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Biomarkers, Tumor MeSH
Pitx2 is a transcription factor responsible for establishment of the right-left axis and development of the gut and pituitary. In mouse embryos, Pitx2 is expressed in the greater curvature of the stomach and midgut. Previously, Pitx2 was studied in pituitary neuroendocrine tumours but not in other NETs. Pitx2 expression was immunohistochemically assessed in whole sections and tissue microarrays in a cohort of 224 neuroendocrine neoplasms, and was analysed in 29 cases. The cohort included 18 cauda equina NETs, 38 paragangliomas, 98 cases of primary visceral NETs from different organs, 23 metastases of visceral NETs and 47 neuroendocrine carcinomas (NECs). Pitx2 expression was observed in 29.5% (29 of 98) NETs and 14.9% (7 of 47) NECs, but was not observed in any paraganglioma or cauda equina NET. Pitx2 was observed only in tumours of midgut-derived organs, including the small intestine (100%, 20 of 20), appendix (88.9%, eight of nine) and large intestine (9.1%, one of 11 - only caecal NET). The NETs of remaining locations were negative. Pitx2 was 96.7% sensitive and 100% specific for NETs of midgut origin. In NECs, Pitx2 positivity was observed in goblet cell adenocarcinoma (75%, three of four), medullary thyroid carcinoma (42.9, three of seven) and one Merkel cell carcinoma (25%, one of four). In metastatic NETs, Pitx2 was observed in all the tumours originating in the small intestine (n = 17) or caecum (n = 1). No positivity was observed in tumours from other locations (four pancreas, one lung). We observed no correlation between immunoreactivity and mRNA expression. Thus, Pitx2 immunohistochemistry can be helpful in assessing the midgut origin of NETs.
See more in PubMed
Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum. Pathol. 2020; 96; 8-33.
Chai SM, Brown IS, Kumarasinghe MP. Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates. Histopathology 2018; 72; 153-167.
Mamilla D, Manukyan I, Fetsch PA, Pacak K, Miettinen M. Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors. Hum. Pathol. 2020; 103; 72-82.
Tang LH, Basturk O, Sue JJ, Klimstra DS. A practical approach to the classification of who grade 3 (g3) well-differentiated neuroendocrine tumor (wd-net) and poorly differentiated neuroendocrine carcinoma (pd-nec) of the pancreas. Am. J. Surg. Pathol. 2016; 40; 1192-1202.
Rindi G, Klimstra DS, Abedi-Ardekani B et al. A common classification framework for neuroendocrine neoplasms: an international agency for research on cancer (iarc) and world health organization (who) expert consensus proposal. Mod. Pathol. 2018; 31; 1770-1786.
Lin X, Saad RS, Luckasevic TM, Silverman JF, Liu Y. Diagnostic value of cdx-2 and ttf-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin. Appl. Immunohistochem. Mol. Morphol. 2007; 15; 407-414.
Semina EV, Reiter R, Leysens NJ et al. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, rieg, involved in rieger syndrome. Nat. Genet. 1996; 14; 392-399.
Campione M, Steinbeisser H, Schweickert A et al. The homeobox gene pitx2: mediator of asymmetric left-right signaling in vertebrate heart and gut looping. Development 1999; 126; 1225-1234.
Shiratori H, Yashiro K, Shen MM, Hamada H. Conserved regulation and role of pitx2 in situs-specific morphogenesis of visceral organs. Development 2006; 133; 3015-3025.
Torlopp A, Khan MA, Oliveira NM et al. The transcription factor pitx2 positions the embryonic axis and regulates twinning. Elife 2014; 3; e03743.
Drouin J, Lamolet B, Lamonerie T, Lanctot C, Tremblay JJ. The ptx family of homeodomain transcription factors during pituitary developments. Mol. Cell. Endocrinol. 1998; 140; 31-36.
Cox CJ, Espinoza HM, McWilliams B et al. Differential regulation of gene expression by pitx2 isoforms. J. Biol. Chem. 2002; 277; 25001-25010.
Schweickert A, Campione M, Steinbeisser H, Blum M. Pitx2 isoforms: Involvement of pitx2c but not pitx2a or pitx2b in vertebrate left-right asymmetry. Mech. Dev. 2000; 90; 41-51.
Luo J, Yao Y, Ji S et al. Pitx2 enhances progression of lung adenocarcinoma by transcriptionally regulating wnt3a and activating wnt/beta-catenin signaling pathway. Cancer Cell Int. 2019; 19; 96.
Huang Y, Guigon CJ, Fan J, Cheng SY, Zhu GZ. Pituitary homeobox 2 (pitx2) promotes thyroid carcinogenesis by activation of cyclin d2. Cell Cycle 2010; 9; 1333-1341.
He Y, Gong P, Wang S, Xu Q, Chen J. The significance of homeodomain transcription factor 2 in colon cancer cells. Biomed. Eng. Online 2021; 20; 81.
Tamura R, Ohara K, Morimoto Y et al. Pitx2 expression in non-functional pituitary neuroendocrine tumor with cavernous sinus invasion. Endocr. Pathol. 2019; 30; 81-89.
Soukup J, Hornychova H, Manethova M et al. Predictive and prognostic significance of tumour subtype, sstr1-5 and e-cadherin expression in a well-defined cohort of patients with acromegaly. J. Cell. Mol. Med. 2021; 25; 2484-2492.
Skarkova V, Kralova V, Krbal L, Matouskova P, Soukup J, Rudolf E. Oxaliplatin and irinotecan induce heterogenous changes in the emt markers of metastasizing colorectal carcinoma cells. Exp. Cell Res. 2018; 369; 295-303.
Hruz T, Laule O, Szabo G et al. Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes. Adv. Bioinformat. 2008; 2008; 420747.
Ryan AK, Blumberg B, Rodriguez-Esteban C et al. Pitx2 determines left-right asymmetry of internal organs in vertebrates. Nature 1998; 394; 545-551.
Al Alam D, Sala FG, Baptista S et al. Fgf9-pitx2-fgf10 signaling controls cecal formation in mice. Dev. Biol. 2012; 369; 340-348.
Guo X, Lv J, Xi R. The specification and function of enteroendocrine cells in drosophila and mammals: A comparative review. FEBS J. 2021; 289; 4773-4796.
Gehart H, van Es JH, Hamer K et al. Identification of enteroendocrine regulators by real-time single-cell differentiation mapping. Cell 2019; 176; e1116.
Beucher A, Gjernes E, Collin C et al. The homeodomain-containing transcription factors arx and pax4 control enteroendocrine subtype specification in mice. PLoS One 2012; 7; e36449.
Beumer J, Puschhof J, Bauza-Martinez J et al. High-resolution mrna and secretome atlas of human enteroendocrine cells. Cell 2020; 182; 1062-1064.
UniProt C. Uniprot: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021; 49; D480-D489.
Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms